While CropLife International (CLI) primarily contributes to ABS discussions important to the agricultural biotechnology industry, our contributions are often characteristic of the broader concerns of industry. One such common concern is that ABS discussions have become dominated by approaches which limit access — such as disclosure of the source of genetic resources and certificates — while often neglecting the ultimate goal: the sharing of benefits. This emphasis on approaches which limit access detracts from discussing important issues in benefit sharing, such as the development of effective national ABS regimes; material transfer agreements, capacity building; and the management of commensurate required resources.
As we press forward toward 2010, I believe we should not overlook the valuable efforts and accomplishments of past negotiations. The Bonn Guidelines provide an excellent roadmap to develop and maintain national ABS regimes; yet, we have strayed from emphasizing the value of that important document. The inter-relation of national regimes, created and functioning in the spirit of Bonn, should be a principal focus in our international regime discussions. Similarly, given the countless challenges in the ABS issue and limited time available, our previous efforts on gap analysis should be revisited. Our gap analysis has already determined the priority areas that require our attention between now and COP-9.
Moving forward, CLI will continue to participate in the ABS negotiations and remains steadfastly supportive of the CBD objectives. I believe industry provides important intellectual capacity, and pragmatic leadership, which can help bridge the best ideas and practices in both traditional knowledge and science-based agricultural innovation. Reconciling the structural issues related to the creation of information and development of knowledge must be a priority for the CBD and industry moving forward. The benefit to the global community is clear. The need for action to meet our 2010 goals is also clear. We, as stakeholders must mutually promote innovation while fostering a transparent equitable sharing of benefits from the development of biological resources. CropLife International, as a dedicated partner in this global convention remains eager to meet the new challenges which arise as we move forward in our international regime discussions.
Summary of recommendations
Industry representatives can add value by helping in the development of clear frameworks, the clarification and promotion of the commercial and societal value of genetic resources, and the raising of consumer awareness of ABS.
As we proceed forward, CLI and industry representatives can effectively provide input (both independently as well as through other delegations) to the more substantive discussions concerning disclosure and certificates.
The Bonn Guidelines remain an excellent roadmap for the development and sustainability of national ABS regimes. The inter-relation of national regimes, created and functioning in the spirit of Bonn should be a principal focus in our continued international regime discussions.
is President and CEO,
CropLife International.
